生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
KUSA-H1(RCB1990)
,
9-15C(RCB2323)
,
UV♀2(RCB1994)
,
StromaNKtert(RCB2350)
|
68568
|
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells.
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Jurkat
|
62986
|
Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells.
|
Inflammation |
2021-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
K562
|
61335
|
Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes the Expansion of Human Promyelocytic Leukemia Cell Line, NB4.
|
Anticancer Res |
2016-7-1 |
Pubmed
|
ヒト・動物細胞
|
SQ-5(RCB0110)
|
52012
|
The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.
|
Radiother Oncol |
2016-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
PC-9(RCB4455)
|
51659
|
Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.
|
Int J Oncol |
2016-5-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
StromaNKtert(RCB2350)
|
45452
|
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.
|
Leukemia |
2015-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
|
44119
|
Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods.
|
Drug Metab Dispos |
2013-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
ST2(RCB0224)
|
41953
|
Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2.
|
Biochem Pharmacol |
2003-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
KUSA-H1(RCB1990)
,
9-15C(RCB2323)
,
TSt-4(RCB2116)
|
17604
|
The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia.
|
Blood |
2011-9-29 |
Pubmed
Full text
|